Phreesia Inc. Faces Securities Fraud Lawsuit Filed by Schall Law Firm
Phreesia, Inc. is facing a class action lawsuit alleging violations of federal securities laws. Investors claim the company made misleading statements about its growth outlook and financial projections.
Business News — Phreesia, Inc. (NYSE: PHR) is subject to a class action lawsuit alleging violations of federal securities laws, according to a February 2026 announcement from the Schall Law Firm. The lawsuit targets alleged misrepresentations made by the company to investors between May 8, 2025, and March 30, 2026.
The complaint contends that Phreesia provided false and misleading statements regarding its business. Specifically, the company is accused of lacking a reliable basis for its long-term growth outlook and its confidence in projections for fiscal year 2027. Furthermore, Phreesia allegedly claimed that pharmaceutical marketing commitments would drive growth in its Network Solutions segment, despite underlying uncertainties that put revenue targets at risk.
Investors who purchased Phreesia securities during the class period allegedly suffered damages when the market learned the truth about the company's statements. The Schall Law Firm is encouraging investors who experienced losses to contact them by July 13, 2026, to discuss their rights.
The lawsuit alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5. The case is in its early stages, and a class certification has not yet been granted. Investors can choose to participate in the lawsuit or remain an absent class member.